Current Clinical Research Trials for Multiple Sclerosis

Researchers at The GW Medical Faculty Associate’s Department of Neurology & Rehabilitation Medicine are conducting clinical research trials to learn more about treating multiple sclerosis (MS). 

Clinical research trials search for new ways to prevent, understand and/or treat disease. The goal of these trials is to see if a new treatment, procedure or device works and is safe to use.  Participating in a research trial, as either a healthy volunteer or a patient volunteer, is an opportunity to help researchers find better treatments for others in the future.

The following are clinical research trials specific to Multiple Sclerosis:

 

PASSAGE

Study Title: PASSAGE: Long-term, prospective, multinational, paralell-cohort study monitoring safety in patients with MS newly started on fingolimod once daily or treated with another approved disease-modifying therapy

Principal Investigator: Ted Rothstein, MD

Sponsor: Novartis

Study Description: The purpose of this observational study is to assess the overall long-term clinical effectiveness of and to monitor the safety and tolerability of fingolimod (Gilenya™) in patients with relapsing forms of MS in routine clinical practice.

Contact Information: For more information, interested participants and clinicians may contact the Neurology Clinical Research unit at neurostudies@mfa.gwu.edu